Ptc Therapeutics (PTCT) EPS (Basic) (2016 - 2025)
Historic EPS (Basic) for Ptc Therapeutics (PTCT) over the last 14 years, with Q3 2025 value amounting to $0.2.
- Ptc Therapeutics' EPS (Basic) rose 11438.85% to $0.2 in Q3 2025 from the same period last year, while for Sep 2025 it was $9.61, marking a year-over-year increase of 26178.45%. This contributed to the annual value of -$4.73 for FY2024, which is 4351.7% up from last year.
- According to the latest figures from Q3 2025, Ptc Therapeutics' EPS (Basic) is $0.2, which was up 11438.85% from -$0.83 recorded in Q2 2025.
- In the past 5 years, Ptc Therapeutics' EPS (Basic) registered a high of $11.09 during Q1 2025, and its lowest value of -$2.66 during Q2 2023.
- In the last 5 years, Ptc Therapeutics' EPS (Basic) had a median value of -$1.76 in 2023 and averaged -$0.94.
- In the last 5 years, Ptc Therapeutics' EPS (Basic) plummeted by 8349.51% in 2021 and then surged by 102416.67% in 2025.
- Quarter analysis of 5 years shows Ptc Therapeutics' EPS (Basic) stood at -$2.02 in 2021, then dropped by 16.83% to -$2.36 in 2022, then grew by 12.71% to -$2.06 in 2023, then skyrocketed by 58.38% to -$0.86 in 2024, then surged by 123.33% to $0.2 in 2025.
- Its last three reported values are $0.2 in Q3 2025, -$0.83 for Q2 2025, and $11.09 during Q1 2025.